Rabies Diagnostics Market Size, Trends and Outlook by Method (Fluorescent Antibody Test (FAT), Serology Tests, and Others), by Technology (ELISA/Immunohistochemistry, and Others), by End User (Hospitals Diagnostic centers, others) - Global Forecast till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

Chapter 3. Research Methodology

3.1. Introduction

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

Chapter 4. Market Dynamics

4.1. Drivers

4.2. Restraints

4.3. Opportunities

4.4. Challenges

4.5. Macroeconomic Indicators

Chapter 5. Market Factor Analysis

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.3. Investment Feasibility Analysis

Chapter 6. Global Rabies Diagnostics Market, by Method

6.1. Introduction

6.2. Fluorescent antibody test (FAT)

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

6.3. Immunohistochemical Test

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

6.4. Amplification Methods

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

6.5. Histologic Examination

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

6.6. Serology Tests

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

Chapter 7. Global Rabies Diagnostics Market, by Technology

7.1. Introduction

7.2. ELISA/Immunohistochemistry

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

7.3. Chromatography Techniques

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

7.4. PCR

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

7.5. Others

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

Chapter 8. Global Rabies Diagnostics Market, by End User

8.1. Introduction

8.2. Hospitals

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

8.3. Diagnostic centers

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

8.4. Cancer Palliative care clinics

Market Estimates & Forecast, by Region, 2024–2032

Market Estimates & Forecast, by Country, 2024–2032

8.5. Others

Chapter 9. Global Rabies Diagnostics Market, by Region

9.1. Introduction

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

Chapter 10. Company Landscape

10.1. Introduction

10.2. Market Share Analysis

10.3. Key Developments & Strategies

Chapter 11. Company Profiles

11.1. Bio-Rad Laboratories, Inc.

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Merck KGaA

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Aviva Systems Biology Corporation

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Creative Diagnostics

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Demeditec Diagnostics GmbH

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Abbexa Ltd.

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Norgen Biotek Corp.

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. BioNote, Inc.

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Express Biotech International Inc.

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. MyBioSource.com.

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. BioGen Technologies

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. Others

Chapter 12. MRFR Conclusion

12.1. Key Findings

12.1.1. From CEO’s Viewpoint

12.1.2. Unmet Needs of the Market

12.2. Key Companies to Watch

12.3. Predictions for the Rabies Diagnostics Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1. Global Rabies Diagnostics Market Synopsis, 2024–2032

Table 2. Global Rabies Diagnostics Market Estimates and Forecast, 2024–2032 (USD Billion)

Table 3. Global Rabies Diagnostics Market, by Region, 2024–2032 (USD Billion)

Table 4. Global Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 5. Global Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 6. Global Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 7. North America: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 8. North America: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 9. North America: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 10. US: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 11. US: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 12. US: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 13. Canada: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 14. Canada: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 15. Canada: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 16. Latin America: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 17. Latin America: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 18. Latin America: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 19. Europe: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 20. Europe: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 21. Europe: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 22. Western Europe: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 23. Western Europe: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 24. Western Europe: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 25. Eastern Europe: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 26. Eastern Europe: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 27. Eastern Europe: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 28. Asia-Pacific: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 29. Asia-Pacific: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 30. Asia-Pacific: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

Table 31. Middle East & Africa: Rabies Diagnostics Market, by Method, 2024–2032 (USD Billion)

Table 32. Middle East & Africa: Rabies Diagnostics Market, by Technology, 2024–2032 (USD Billion)

Table 33. Middle East & Africa: Rabies Diagnostics Market, by End User, 2024–2032 (USD Billion)

LIST OF FIGURES

Figure 1. Research Process

Figure 2. Segmentation for Global Rabies Diagnostics Market

Figure 3. Segmentation Market Dynamics for Global Rabies Diagnostics Market

Figure 4. Global Rabies Diagnostics Market Share, by Method, 2020

Figure 5. Global Rabies Diagnostics Market Share, by Technology, 2020

Figure 6. Global Rabies Diagnostics Market Share, by End User, 2020

Figure 7. Global Rabies Diagnostics Market Share, by Region, 2020

Figure 8. North America: Rabies Diagnostics Market Share, by Country, 2020

Figure 9. Europe: Rabies Diagnostics Market Share, by Country, 2020

Figure 10. Asia-Pacific: Rabies Diagnostics Market Share, by Country, 2020

Figure 11. Middle East & Africa: Rabies Diagnostics Market Share, by Country, 2020

Figure 12. Global Rabies Diagnostics Market: Company Share Analysis, 2020 (%)

Figure 13. Bio-Rad Laboratories, Inc.: Key Financials

Figure 14. Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 15. Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 16. Merck KGaA: Key Financials

Figure 17. Merck KGaA: Segmental Revenue

Figure 18. Merck KGaA: Geographical Revenue

Figure 19. Aviva Systems Biology Corporation: Key Financials

Figure 20. Aviva Systems Biology Corporation: Segmental Revenue

Figure 21. Aviva Systems Biology Corporation: Geographical Revenue

Figure 22. Creative Diagnostics: Key Financials

Figure 23. Creative Diagnostics: Segmental Revenue

Figure 24. Creative Diagnostics: Geographical Revenue

Figure 25. Demeditec Diagnostics GmbH: Key Financials

Figure 26. Demeditec Diagnostics GmbH: Segmental Revenue

Figure 27. Demeditec Diagnostics GmbH: Geographical Revenue

Figure 28. Abbexa Ltd.: Key Financials

Figure 29. Abbexa Ltd.: Segmental Revenue

Figure 30. Abbexa Ltd.: Geographical Revenue

Figure 31. Norgen Biotek Corp.: Key Financials

Figure 32. Norgen Biotek Corp.: Segmental Revenue

Figure 33. Norgen Biotek Corp.: Geographical Revenue

Figure 34. BioNote, Inc.: Key Financials

Figure 35. BioNote, Inc.: Segmental Revenue

Figure 36. BioNote, Inc.: Geographical Revenue

Figure 37. Express Biotech International Inc.: Key Financials

Figure 38. Express Biotech International Inc.: Segmental Revenue

Figure 39. Express Biotech International Inc.: Geographical Revenue

Figure 40. MyBioSource.com.: Key Financials

Figure 41. MyBioSource.com.: Segmental Revenue

Figure 42. MyBioSource.com.: Geographical Revenue

Figure 43. BioGen Technologies: Key Financials

Figure 44. BioGen Technologies: Segmental Revenue

Figure 45. BioGen Technologies: Geographical Revenue